newsfilter
← Latest News
GlobeNewswire·

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (NASDAQ:GCTK), a medical device company focused on the design, development, and commercialization of novel